Dialogue with Nagashree Seetharamu

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Dialogue with Nagashree Seetharamu

Feb 5, 2024, 03:55 | Dialogues

OncoInfluencers: Dialogue with Nagashree Seetharamu, hosted by Gevorg Tamamyan

Join us for an exciting episode of “OncoInfluencers,” with our host Dr. Gevorg Tamamyan. In…

All: 1 Posts: 1 - 100

'

Agenus Bets Big on Botensilimab

'

Carlos Rodriguez-Galindo: Childhood cancer has long been overlooked in global strategies - It is time to change that

'

EMBER-3 Trial Updates from ESMO Breast 2025: Imlunestrant Plus Abemaciclib Improves PFS in CDK4/6i-Pretreated ER+/HER2- Breast Cancer

'

Happy Birthday OncoDaily!

'

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023